newsfilter
← Latest News
GlobeNewswire·

Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026

  • Inspire Medical Systems (NYSE: INSP) will report Q2 2026 financial results after market close on Monday, August 3, 2026.
  • The management team will host a conference call at 5:00 p.m. Eastern Time to discuss results & business developments.
  • A webcast of the call will be available via the Investor Relations page or the provided link for listening.
  • Participants wishing to ask questions must register via the specific link to receive dial-in details & a unique access code.
  • The Company recommends registering at least 10 minutes before the call begins to ensure connectivity.
  • A replay of the call will be available on the Investor Relations website approximately two hours after the event & archived for two weeks.
  • Inspire is a medical technology company developing minimally invasive solutions for obstructive sleep apnea.
  • Its Inspire therapy is the first FDA, EU MDR, & PDMA-approved neurostimulation technology for moderate to severe obstructive sleep apnea.
  • Investor & media contact Ezgi Yagci can be reached at ezgiyagci@inspiresleep.com or 617-549-2443.